Bain Capital Life Sciences Fund II L.P. 13D and 13G filings for Nuvalent, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-29 5:16 pm Unchanged | 2024-03-27 | 13D | Nuvalent, Inc. NUVL | Bain Capital Life Sciences Fund II L.P. | 2,400,630 4.100% | 0 (Unchanged) | Filing |
| 2023-10-20 4:30 pm Unchanged | 2023-10-19 | 13D | Nuvalent, Inc. NUVL | Bain Capital Life Sciences Fund II L.P. | 2,400,630 4.200% | 0 (Unchanged) | Filing |
| 2022-11-03 4:15 pm Unchanged | 2022-11-03 | 13D | Nuvalent, Inc. NUVL | Bain Capital Life Sciences Fund II L.P. | 2,400,630 4.800% | 0 (Unchanged) | Filing |
| 2021-08-04 5:11 pm Purchase | 2021-08-02 | 13D | Nuvalent, Inc. NUVL | Bain Capital Life Sciences Fund II L.P. | 2,400,630 5.600% | 2,400,630 (New Position) | Filing |